Zobrazeno 1 - 10
of 493
pro vyhledávání: '"D. Cellier"'
Autor:
Jean-Christophe Pagès, Jean-Jacques Leguay, Yves Bertheau, Pascal Boireau, Denis Bourguet, Florence Coignard, François Coléno, Jean-Luc Darlix, Elie Dassa, Maryse Deguergue, Hubert De Verneuil, Robert Drillien, Anne Dubart-Kupperchmitt, Nicolas Ferry, Claudine Franche, Philippe Guerche, Joël Guillemain, Mireille Jacquemond, André Jestin, Bernard Klonjkowski, Marc Lavielle, Jane Lecomte, Olivier Le Gall, Stéphane Lemarié, Didier Lereclus, Rémy Maximilien, Antoine Messéan, Bertrand Ney, Jacques Pagès, Daniel Parzy, Catherine Regnault-Roger, Pierre Rougé, Patrick Saindrenan, Pascal Simonet, Virginie Tournay, Bernard Vaissière, Jean-Luc Vilotte
Publikováno v:
[Autre] Haut Conseil des biotechnologies. 2009, 8 p
HAL
HAL
Le HCB a fait siennes les observations selon lesquelles les faiblesses des analyses statistiques interdisent de conclure avec suffisamment de certitude à l'absence de risques sanitaires et environnementaux liés aux OGM. Ces faiblesses sont aujourd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::8f4dd1864f6931f59008d66ee913d724
https://hal.inrae.fr/hal-02916040
https://hal.inrae.fr/hal-02916040
Autor:
J. Fayette, C. Dalban, P. Zrounba, S. Racadot, D. Girodet, S. Chabaud, E. Reyt, M. Poupart, J.M. Prades, M. Burgy, D. Cellier, P. Ceruse, J. Leval, P. Muller, P. Manipoud, I.L. Ray-Coquard, G. Thibault
Publikováno v:
Annals of Oncology. 33:S850-S851
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::485f58a0dc067ee3cd492ea4756a0336
https://doi.org/10.1016/j.annonc.2022.07.798
https://doi.org/10.1016/j.annonc.2022.07.798
Autor:
W. G. Kim, Daniele Garbin, D. Cellier, Robin Degraeve, Sergiu Clima, S. Kabuyanagi, Mahendra Pakala, A. Cockburn, G. L. Donadio, Andrea Fantini, Wouter Devulder, Gouri Sankar Kar, M. Suzuki, Ludovic Goux, Romain Delhougne
Publikováno v:
2020 IEEE Symposium on VLSI Technology.
Switching mechanism and its controllability in Ovonic Threshold Switching (OTS) devices are systematically investigated by using Si-Ge-As-Se quaternary system known as promising OTS materials. We newly demonstrate that selector device performance is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cdcb8bfe4858a488ad7b70590df0dee
https://doi.org/10.1109/vlsitechnology18217.2020.9265011
https://doi.org/10.1109/vlsitechnology18217.2020.9265011
Autor:
Wouter Devulder, Romain Delhougne, W. G. Kim, Andrea Fantini, Gouri Sankar Kar, Sergiu Clima, Christophe Detavernier, A. Cockburn, Mahendra Pakala, Robin Degraeve, Ludovic Goux, Karl Opsomer, G. L. Donadio, D. Cellier, Daniele Garbin
Publikováno v:
2019 IEEE International Electron Devices Meeting (IEDM).
In this work we explore the composition space of the Ovonic Threshold Switch (OTS) selector device based on Si-Ge-As-Te material system. Physical Vapor Deposition (PVD) co-sputtering capabilities enabled the tuning of the As/Te ratio, Ge and Si conte
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::310b449b2b421dd6dc7c2ce077a73ade
https://doi.org/10.1109/iedm19573.2019.8993547
https://doi.org/10.1109/iedm19573.2019.8993547
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Anne Mathieu-Boué, Pierre Demolis, Jean-François Bergmann, M. Aoustin, C. Atlani, F. Bassompierre, R. Benamouzig, M.-J. Bonavita, L. Borella, F. Calvo, C. Caulin, D. Cellier, M. Dahan, V. Daura, F. De Beels, N. De Vernejoul, V. Diebolt, N. Dumarcet, I. Durand Zaleski, E. Fery Lemonnier, J. Genève, I. Giri, D. Golinelli, C. Labreveux, J.-F. Latour, D. Maraninchi, V. Meresse, L. Mignot, D. Morlet, S. Pépin, P. Ravaud, C. Riché, A. Rouleau, P. Tilleul, P. Viens
Publikováno v:
Therapie. 61(4)
Drugs used in oncology represent more than half of the innovative and costly drugs which are not covered by a Group Homogene de Soins (DRG type classification) within the context of the case-mix based payment system (termed T2A). For these drugs, goo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca266e08379d0a664fbfb3face31cfd8
https://pubmed.ncbi.nlm.nih.gov/27393309
https://pubmed.ncbi.nlm.nih.gov/27393309
Autor:
Verdelho Machado, Mariana1,2 (AUTHOR) mverdelhomachado@gmail.com
Publikováno v:
International Journal of Molecular Sciences. Oct2024, Vol. 25 Issue 19, p10383. 19p.
Autor:
Anne Mathieu-Boué, Pierre Demolis, Jean-François Bergmann, M. Aoustin, C. Atlani, F. Bassompierre, R. Benamouzig, M.-J. Bonavita, L. Borella, F. Calvo, C. Caulin, D. Cellier, M. Dahan, V. Daura, F. De Beels, N. De Vernejoul, V. Diebolt, N. Dumarcet, I. Durand Zaleski, E. Fery Lemonnier, J. Genève, I. Giri, D. Golinelli, C. Labreveux, J.-F. Latour, D. Maraninchi, V. Meresse, L. Mignot, D. Morlet, S. Pépin, P. Ravaud, C. Riché, A. Rouleau, P. Tilleul, P. Viens
Publikováno v:
Therapies. 61:305-308
Les medicaments utilises en cancerologie representent plus de la moitie des medicaments innovants et couteux pris en charge hors d'un groupe homogene de soins dans le cadre de la tarification a l'activite. Pour ces medicaments, des referentiels de bo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4014c868cef1c44a0788ee6dcdcd914
https://doi.org/10.2515/therapie:2006054
https://doi.org/10.2515/therapie:2006054
Autor:
Muriel Vray, Bernard Hamelin, Patrice Jaillon, M. Andréjak, R. Benamouzig, J.-P. Boissel, C. Bremard-Oury, C. Brun-Strang, E. Caulin, D. Cellier, D. Costagliola, V. Daurat, A. El Hasnaoui, J.-M. Goehrs, B. Hamelin, P. Jaillon, C. Jouan-Flahault, J.-L. Montastruc, N. Moore, A. Puech, M. Ricatte, P. Ricordeau, M.-H. Rodde-Dunet, E. Rouffiac, T. Simon, P. Simon, A. Spriet, E. Van Ganse, P. Velicitat, M. Vray
Publikováno v:
Therapies. 60:345-349
The respective roles of controlled clinical trials and observational studies (cohort or case-control studies) in evaluating the efficacy, safety and usefulness of a drug were analysed. A randomised, controlled, double-blind study is the best method o
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::569e71e509a59ae9da1111b385f1c829
https://doi.org/10.2515/therapie:2005048
https://doi.org/10.2515/therapie:2005048
Autor:
P. Jaillon, E. Caulin, M. Vray, E. Van Ganse, Alain J. Puech, E. Rouffiac, Jean-Pierre Boissel, Jean-Marie Goehrs, M. Ricatte, D. Cellier, C. Brun-Strang, P. Simon, Patrice Jaillon, A. Spriet, Chrystel Jouan-Flahault, M.-H. Rodde-Dunet, Michel Andrejak, Bernard Hamelin, B. Hamelin, Muriel Vray, Tabassome Simon, J. L. Montastruc, Dominique Costagliola, A El Hasnaoui, P. Ricordeau, C. Bremard-Oury, P. Velicitat, Robert Benamouzig, V. Daurat, Nicholas Moore
Publikováno v:
Therapies. 60:339-344
Resume La place relative des essais cliniques comparatifs et des etudes observationnelles (cohortes ou etudes castemoins) a ete etudiee dans l’objectif d’evaluer l’efficacite, la tolerance et l’interet de sante publique d’un medicament. L
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ab608f0eb393a7b093b5491719086e56
https://doi.org/10.2515/therapie:2005047
https://doi.org/10.2515/therapie:2005047